These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25133471)

  • 1. Karyotype-specific ear and hearing problems in young adults with Turner syndrome and the effect of oxandrolone treatment.
    Verver EJ; Freriks K; Sas TC; Huygen PL; Pennings RJ; Smeets DF; Hermus AR; Menke LA; Wit JM; Otten BJ; van Alfen-van der Velden JA; de Muinck Keizer-Schrama SM; Topsakal V; Admiraal RJ; Timmers HJ; Kunst HP
    Otol Neurotol; 2014 Oct; 35(9):1577-84. PubMed ID: 25133471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both].
    Starzyk J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):79-84. PubMed ID: 15996336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of karyotype on the auricle, otitis media and hearing in Turner syndrome.
    Barrenäs ML; Nylén O; Hanson C
    Hear Res; 1999 Dec; 138(1-2):163-70. PubMed ID: 10575123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.
    Freriks K; Sas TC; Traas MA; Netea-Maier RT; den Heijer M; Hermus AR; Wit JM; van Alfen-van der Velden JA; Otten BJ; de Muinck Keizer-Schrama SM; Gotthardt M; Dejonckere PH; Zandwijken GR; Menke LA; Timmers HJ
    Eur J Endocrinol; 2013 Jan; 168(1):91-9. PubMed ID: 23076845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; van Koningsbrugge SH; de Ridder MA; Zandwijken GR; Boersma B; Dejonckere PH; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ear and hearing problems in relation to karyotype in children with Turner syndrome.
    Verver EJ; Freriks K; Thomeer HG; Huygen PL; Pennings RJ; Alfen-van der Velden AA; Timmers HJ; Otten BJ; Cremers CW; Kunst HP
    Hear Res; 2011 May; 275(1-2):81-8. PubMed ID: 21147207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome.
    Freriks K; Verhaak CM; Sas TC; Menke LA; Wit JM; Otten BJ; de Muinck Keizer-Schrama SM; Smeets DF; Netea-Maier RT; Hermus AR; Kessels RP; Timmers HJ
    Horm Behav; 2015 Mar; 69():59-67. PubMed ID: 25562712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen deficiency and growth hormone treatment in childhood are not associated with hearing in adults with turner syndrome.
    Ostberg JE; Beckman A; Cadge B; Conway GS
    Horm Res; 2004; 62(4):182-6. PubMed ID: 15367813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otologic disorders in Turner syndrome.
    Bois E; Nassar M; Zenaty D; Léger J; Van Den Abbeele T; Teissier N
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):21-24. PubMed ID: 28941966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone and oxandrolone treatment on glucose metabolism in Turner syndrome. A longitudinal study.
    Joss EE; Zurbrügg RP; Tönz O; Mullis PE
    Horm Res; 2000; 53(1):1-8. PubMed ID: 10965213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome?
    Joss EE; Mullis PE; Werder EA; Partsch CJ; Sippell WG
    Horm Res; 1997; 47(3):102-9. PubMed ID: 9050948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss in Turner syndrome.
    Morimoto N; Tanaka T; Taiji H; Horikawa R; Naiki Y; Morimoto Y; Kawashiro N
    J Pediatr; 2006 Nov; 149(5):697-701. PubMed ID: 17095347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual hearing screening in girls with Turner Syndrome: Results from the first three years in Glasgow.
    Kubba H; McAllister K; Hunter K; Mason A
    Int J Pediatr Otorhinolaryngol; 2019 May; 120():152-156. PubMed ID: 30798112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome.
    Han TS; Cadge B; Conway GS
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):643-7. PubMed ID: 17054467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Otologic disease in turner syndrome.
    Dhooge IJ; De Vel E; Verhoye C; Lemmerling M; Vinck B
    Otol Neurotol; 2005 Mar; 26(2):145-50. PubMed ID: 15793396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Zandwijken GR; de Ridder MA; Stijnen T; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):212-9. PubMed ID: 20105186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.